Article

Strategies for Better Treatment Adherence in Children

(AUDIO) Chances are excellent that your young patients aren’t taking their medications as you’ve prescribed them.

Chances are excellent that your young patients aren’t taking their medications as you’ve prescribed them.

Are there effective strategies to help you boost treatment adherence in your pediatric patients with rheumatologic disease? That’s the question we put to D. Michael Rapoff, who is Ralph L. Smith Professor of Pediatrics and Vice Chair for Research and Scholarship in the Department of Pediatrics at the University of Kansas Medical Center in Kansas City. In the next 5 minutes, Dr Rapoff will outline strategies that can help promote adherence to therapy.

References:
-Rapoff MA. Adherence to Pediatric Medical Regimens. 2nd ed. New York: Springer; 2010.
-Rapoff M, Lindsley CB. Improving adherence to medical regimens for juvenile rheumatoid arthritis. Pediatr Rheumatol Online J. 2007;5:10. http://www.ncbi.nlm.nih.gov/pubmed/17550635
-Rapoff MA. Management of adherence and chronic rheumatic disease in children and adolescents. Best Pract Res Clin Rheumatol. 2006;20:301-314.

Strategies for Better Treatment Adherence in Children

Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.